News

Dewpoint

|

May 24, 2022

|

Category:

Assaying Small Molecule Partitioning into Biomolecular Condensates

Poster presented at KEYSTONE SYMPOSIA on Modern Phenotypic Drug Discovery: from Chemical Biology to Therapeutics

> Download the PDF file

Media Contact

media@dewpointx.com

Investor Contact

Scott Peterson, Ph.D.

SVP, Corporate Development and Investor Relations
Dewpoint Therapeutics
speterson@dewpointx.com

Back to News home section

Share:

Dewpoint Therapeutics Appoints Aravind Subramanian, Ph.D., as Head of Digital & Technology Platforms

Targeting biomolecular condensates: A novel opportunity in drug discovery

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA

Home About us Science Pipeline Join us News Contact

Condensates.com

© 2019-2023 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science